Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F8D9W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,730
Award facts
- Contract value 100% obligated
- $12,729.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded December 10, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides Cosentyx (secukinumab) 300mg dose in 2-pen/mL formulation with a ceiling value of $12,729.66 and a firm fixed price structure. The order, which is due for completion by December 11, 2025, is not set-aside and represents a competitively awarded transaction supporting federal medical supply procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this requirement as part of its broader role as a critical vendor for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. The delivery order reflects the company's established capability to fulfill federal medical procurement requirements through open competition and demonstrates the flexibility of the DLA's pharmaceutical prime vendor program in meeting diverse medical supply needs across the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F8D9W?
SPE2DR26F8D9W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F8D9W worth?
The government has obligated $12,730 on SPE2DR26F8D9W.
Is contract SPE2DR26F8D9W an order under another contract?
Yes. SPE2DR26F8D9W is a delivery order under SPE2DR25D3202, an indefinite delivery contract.
Was contract SPE2DR26F8D9W competed?
The extent of competition for SPE2DR26F8D9W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award